Brookdale Senior Living I... (BKDT)
NYSE: BKDT
· Real-Time Price · USD
77.60
0.00 (0.00%)
At close: Mar 28, 2025, 3:53 PM
Brookdale Senior Living 7. Revenue Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|---|---|---|---|
Health Care, Resident Service Revenue | 775.61M | 777.45M | 1.49B | 743.73M | 739.71M | 1.43B | 717.12M | 710.16M |
Health Care, Resident Service Revenue Growth | -0.24% | -47.77% | +100.16% | +0.54% | -48.27% | +99.41% | +0.98% | n/a |
Management Service Revenue | 2.62M | 2.62M | 5.23M | 2.68M | 2.62M | 5.08M | 2.57M | 2.51M |
Management Service Revenue Growth | +0.11% | -49.89% | +95.40% | +2.29% | -48.55% | +98.17% | +2.23% | n/a |
Reimbursement Costs, Managed Communities Revenue | 34.71M | 33.79M | 69.94M | 37.76M | 35.22M | 70.35M | 34.98M | 34M |
Reimbursement Costs, Managed Communities Revenue Growth | +2.71% | -51.69% | +85.21% | +7.23% | -49.94% | +101.11% | +2.88% | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 2.1M | 101.13M | 89.36M | 98.8M | 99.67M | 98.8M | 96.3M | 97.97M | 97.45M | 92.8M | 82.62M | 83.92M | 84.62M | 87.84M | 82.93M | 87.73M | 100.09M | 97.32M | 93.8M | 104.26M | 116.46M | 121.94M | 114.96M | 124.28M | 129.24M | 129.14M | 124.17M | 125.97M | 139.86M | 144.68M | 138M | 148.22M | 151.78M | 154.37M | 150.41M | 149.54M | 166.68M | 170.21M | 158.98M | 154.88M | 152.3M | 184M |
Selling, General, and Administrative Revenue Growth | -97.92% | +13.17% | -9.55% | -0.87% | +0.88% | +2.60% | -1.71% | +0.54% | +5.00% | +12.32% | -1.55% | -0.83% | -3.66% | +5.92% | -5.47% | -12.35% | +2.85% | +3.75% | -10.04% | -10.48% | -4.49% | +6.07% | -7.50% | -3.83% | +0.07% | +4.00% | -1.42% | -9.93% | -3.33% | +4.84% | -6.89% | -2.35% | -1.68% | +2.63% | +0.58% | -10.28% | -2.08% | +7.06% | +2.65% | +1.69% | -17.23% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |